A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort

Autor: Lee, Ming-Jen, Kuo, Hung-Chou, Chou, Lin-Na, Sweetser, Marianne T., Wang, Jiaan-Der
Zdroj: In Journal of the Formosan Medical Association June 2024 123(6):679-686
Databáze: ScienceDirect